Aura Biosciences (AURA) Research & Development (2020 - 2026)
Aura Biosciences (AURA) posted Research & Development of $28.0 million for Q1 2026, up 27.69% on a QoQ basis from $21.9 million in Q4 2025, and up 19.78% year-over-year from $23.3 million in Q1 2025.
Aura Biosciences (AURA) Research & Development (2020 - 2026) Analysis & Trends
Aura Biosciences' Research & Development history runs 7 years deep, the most recent figure standing at $28.0 million for Q1 2026.
- Quarterly Research & Development rose 19.78% year-over-year to $28.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $94.9 million (up 19.25% YoY) and the FY2025 annual result came in at $90.3 million, up 23.19% from the prior year.
- Research & Development was $28.0 million for Q1 2026 at Aura Biosciences, up from $21.9 million in the prior quarter.
- Across five years, Research & Development topped out at $28.0 million in Q1 2026 and bottomed at $8.3 million in Q1 2022.
- A 5-year average of $17.6 million and a median of $17.0 million in 2024 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2022 — Research & Development soared 97.75% — and 2025, when it fell 1.96%.
- Aura Biosciences' Research & Development stood at $13.2 million in 2022, then soared by 54.12% to $20.3 million in 2023, then rose by 10.13% to $22.3 million in 2024, then decreased by 1.96% to $21.9 million in 2025, then grew by 27.69% to $28.0 million in 2026.
- Business Quant data shows AURA's Research & Development at $28.0 million in Q1 2026, $21.9 million in Q4 2025, and $22.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -17.94 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 541.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -2.31 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 961.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.54 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 15.66 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.37 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 343.97 Mn |
| 10 | Aura Biosciences | 485.62 Mn | 400.83 Mn | - | 27.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.96 Mn |
| Dec 31, 2025 | 21.90 Mn |
| Sep 30, 2025 | 22.18 Mn |
| Jun 30, 2025 | 22.88 Mn |
| Mar 31, 2025 | 23.34 Mn |
| Dec 31, 2024 | 22.33 Mn |
| Sep 30, 2024 | 17.04 Mn |
| Jun 30, 2024 | 16.88 Mn |
| Mar 31, 2024 | 17.05 Mn |
| Dec 31, 2023 | 20.28 Mn |
| Sep 30, 2023 | 15.43 Mn |
| Jun 30, 2023 | 15.12 Mn |
| Mar 31, 2023 | 14.41 Mn |
| Dec 31, 2022 | 13.16 Mn |
| Sep 30, 2022 | 11.29 Mn |
| Jun 30, 2022 | 9.51 Mn |
| Mar 31, 2022 | 8.28 Mn |
| Dec 31, 2021 | 7.98 Mn |
| Sep 30, 2021 | 6.37 Mn |
| Jun 30, 2021 | 6.63 Mn |